ArticleBioinformatics (Oxford, England)2026
NicheDeSig: niche-aware deconvolution and adaptive signature analysis for spatial transcriptomics.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
motivationFor spot-based spatial transcriptomics (ST), accurate cell-type deconvolution is essential for downstream analysis since each spot captures mixtures of multiple cell types. Meanwhile, spatial niches define distinct micro-environmental contexts, also salient for biological interpretation. However, existing deconvolution methods usually rely on fixed reference signatures or mapping single cells onto ST spots, without incorporating niche priors or modeling niche-dependent shifts. Consequently, existing methods remain focused on spot-level proportion estimation, with limited ability to support functional analysis of niche-associated molecular programs.
resultsWe present NicheDeSig for niche-aware deconvolution. NicheDeSig models each cell type through adaptive signatures, enabling spot deconvolution under context-dependent signatures and supporting niche-aware analysis of cell-state variation across spatial micro-environments. Our method achieves strong deconvolution performance across the simulated benchmark datasets and improves spatial fidelity in the simulated colon dataset. The learned signatures recover laminar and white-matter-associated programs in the human dorsolateral prefrontal cortex (DLPFC), domain-stratified tumor microenvironment patterns in breast cancer (BRCA), and region-associated signatures in pancreatic ductal adenocarcinoma sample A (PDAC-A) and colorectal liver metastasis analyses. AVAILABILITY AND IMPLEMENTATION: Source code and the archived code snapshot are available at https://github.com/Davidcoach/NicheDeSig and https://doi.org/10.5281/zenodo.20685597.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.